K. Michigami, M. Hayashi / Tetrahedron 69 (2013) 4221e4225
4223
then added and the reaction mixture was stirred for 1 min. After
filtration through Celite, the filtrate was passed through DOWEXÔ
50Wꢂ2 50e100 mesh (H) cation exchange resin and evaporated.
The residue was purified by silica gel column chromatography
[eluent: hexane/ethyl acetate (1/1) then ethyl acetate] to give
604, 755, 918, 1029, 1223, 1370, 1742, 2932, 3000e3500 (br) cmꢀ1; 1H
NMR (400 MHz, CDCl3) 1.68 (br s, 1H, OH), 2.10 (s, 3H, CH3COO), 2.11
d
(s, 3H, CH3COO), 2.94 (br s, 1H, OH), 3.41 (s, 3H, OMe), 3.7e3.8 (m, 2H,
H4; H6), 3.8e3.9 (m, 2H, H5; H60), 4.84 (dd, J¼10.3, 3.3 Hz, 2H, H2),
4.91 (d, J¼3.3 Hz, 1H, H1), 5.2e5.3 (m, 1H, H3); 13C NMR (100.6 MHz,
methyl 2,3-O-protected-
D
-glucopyranoside.
CDCl3): d 20.8, 20.9, 55.3, 62.0, 69.9, 70.7, 71.1, 73.4, 96.8, 170.3, 172.0;
HRMS [ESI]. m/z calcd for C11H18O8Na: 301.0899 [MþNa]þ, found:
301.0899 [MþNa]þ; Anal. Calcd for C11H18O8: C, 47.48; H, 6.52. Found:
C, 47.48; H, 6.52.
3.2.1. Methyl 2,3-di-O-benzyl-a-D-glucopyranoside (1). White solids;
mp 73e75 ꢁC, (lit.10 mp 73e75 ꢁC); ½a 2D4
ꢃ
þ19.3 (c 1.0, CHCl3) (lit.10
½ ꢃ
a 2D4
þ18.1 (c 1.0, CHCl3)); IR (KBr) 696, 735, 754, 1000, 1023, 1044, 1057,
1119, 3200e3600 (br) cmꢀ1; 1H NMR (400 MHz, CDCl3)
d
1.97 (br s, 1H,
3.2.7. Methyl 2,3-di-O-benzoyl-a-D-glucopyranoside (7). White solids;
OH), 2.33 (br s, 1H, OH), 3.39 (s, 1H, OMe), 3.4e3.6 (m, 2H, H2; H4),
3.6e3.7 (m, 1H, H5), 3.7e3.8 (m, 3H, H3; H6; H60), 4.66 (d, J¼3.2 Hz,
1H, OCH2Ph), 4.70 (d, J¼12.0 Hz, 1H, OCH2Ph), 4.74 (d, J¼12.0 Hz, 1H,
OCH2Ph), 5.03 (d, J¼3.2 Hz, 1H, H1), 7.3e7.4 (m, 10H, PhH); 13C NMR
mp 63e65 ꢁC; ½a 2D9
ꢃ
þ178.2 (c 1.0, CHCl3) (lit.14
½
a 1D9
ꢃ
þ165.6 (c 1.0,
CHCl3)); IR (KBr) 696, 739, 961, 1028, 1045, 1094, 1194, 1275, 1354,
1
1453, 1722, 2928, 3000e3500 (br) cmꢀ1; H NMR (400 MHz, CDCl3)
d
1.72 (br s, 1H, OH), 2.16 (br s, 1H, OH), 3.43 (s, 3H, OMe), 3.86 (ddd,
(100.6 MHz, CDCl3):
d
55.2, 62.4, 70.3, 70.6, 73.1, 75.4, 76.7, 79.7, 81.2,
J¼6.7, 6.7, 3.1 Hz, 1H, H5), 3.9e4.0 (m, 3H, H4; H6; H60), 5.12 (d,
J¼3.9 Hz, 1H, H1), 5.23 (dd, J¼3.9, 9.5 Hz, 1H, H2), 5.74 (dd, J¼10.3,
9.5 Hz, 1H, H3), 7.3e7.4 (m, 4H, PhH), 7.5e7.6 (m, 2H, PhH), 7.9e8.0 (m,
98.1, 127.9, 128.0, 128.1, 128.5, 128.6, 137.9, 138.6; HRMS [ESI]. m/z calcd
for C21H25O6: 373.1651 [MꢀH]ꢀ, found: 373.1644 [MꢀH]ꢀ; Anal. Calcd
for C21H26O6: C, 67.36; H, 7.00. Found: C, 66.99; H, 6.83.
4H, PhH); 13C NMR (100.6 MHz, CDCl3):
d 55.4, 62.1, 69.6, 71.3, 71.5,
74.3, 97.1,128.4,129.08,129.15,129.87,129.88,133.3,133.5,166.0,167.5;
HRMS [ESI]. m/z calcd for C21H21O8: 401.1236 [MꢀH]ꢀ, found:
401.1237 [MꢀH]ꢀ.
3.2.2. Methyl 2,3-di-O-benzyl-b-D-glucopyranoside (2). White solids;
a 30
ꢁ
mp 113 C; ½ ꢃD þ19.0 (c 0.5, CHCl3); IR (KBr) 560, 648, 696, 721, 732,
993, 1029, 1062, 1093, 1118, 3100e3500 (br) cmꢀ1; 1H NMR (400 MHz,
CDCl3)
d
2.04 (br s, 1H, OH), 2.28 (br s, 1H, OH), 3.3e3.4 (m, 1H, H5),
3.2.8. Methyl 2,3-di-O-benzyl-
a
-
-galactopyranoside (8). Colorless oil;
þ46.9 (c 0.67, CHCl3) (lit.15
½
aDꢃ2D9 þ43 (c 0.67, CHCl3)); IR (KBr) 686,
3.41 (dd, J¼8.6, 7.8 Hz, 1H, H2), 3.45 (dd, J¼9.0, 8.6 Hz, 1H, H3), 3.58 (s,
1H, OMe), 3.77 (dd, J¼11.9, 5.0 Hz, 1H, H6), 3.89 (dd, J¼11.9, 3.2 Hz, 1H,
H60), 4.37 (d, J¼7.6 Hz, 1H, H1), 4.67 (d, J¼11.6 Hz, 1H, PhCH2), 4.71 (d,
J¼11.2 Hz, 1H, PhCH2), 4.93 (d, J¼11.2 Hz, 1H, PhCH2), 4.97 (d,
J¼11.6 Hz, 1H, PhCH2), 7.2e7.4 (m, 10H, PhH); 13C NMR (100.6 MHz,
½
a 2D9
ꢃ
706, 991, 1025, 1068, 1094, 1275, 1451, 1720, 2933, 3000e3500 br
cmꢀ1; 1H NMR (400 MHz, CDCl3)
d 2.46 (br s, 1H, OH), 2.78 (br s, 1H,
OH), 3.37 (s, 3H, OMe), 3.7e3.9 (m, 5H, H2; H3; H5; H6; H60), 4.0e4.1
(m, 1H, H4), 4.67 (d,1H, PhCH2), 4.69 (d, J¼11.9 Hz, 1H, PhCH2), 4.70 (d,
J¼3.2 Hz, 1H, H1), 4.81 (d, J¼11.9 Hz, 2H, PhCH2), 7.3e7.4 (m, 10H,
CDCl3): d 57.3, 62.7, 70.5, 74.6, 74.8, 75.2, 82.0, 83.8, 105.0, 127.7, 127.9,
128.0, 128.1, 128.4, 128.6, 138.3, 138.5; HRMS [ESI]. m/z calcd for
C21H25O6: 373.1651 [MꢀH]ꢀ, found: 373.1657 [MꢀH]ꢀ; Anal. Calcd for
C21H26O6: C, 67.36; H, 7.00. Found: C, 67.43; H, 7.17.
PhH); 13C NMR (100.6 MHz, CDCl3):
d 55.3, 63.0, 68.8, 69.1, 72.9, 73.5,
75.6, 98.6,127.8,127.9,128.0,128.4,128.5,138.0,138.2; HRMS [ESI]. m/z
calcd for C21H25O6: 373.1651 [MꢀH]ꢀ, found: 373.1650 [MꢀH]ꢀ.
3.2.3. Methyl 2,3-di-O-methyl-
a
-
D
-glucopyranoside (3). White solids;
3.3. General procedure for asymmetric alkylation using
diethylzinc
mp 78e80 ꢁC (lit.11 83e85 ꢁC); White solids; ½a 2D7
þ151.5 (c 1.0, CHCl3)
ꢃ
(lit.11
½
a 2D3
ꢃ
þ151.5 (c 1.0, CHCl3)); IR (KBr) 567, 628, 705, 745, 853, 904,
960, 894, 1025, 1050, 1073, 1104, 1134, 3100e3600 (br) cmꢀ1; 1H NMR
(400 MHz, CDCl3) 2.07 (br s, 1H, OH), 2.18 (br s, 1H, OH), 3.23 (dd,
To a mixture of catalyst (0.2 mmol) and solvent (0.75 mL) was
added diethylzinc (5.0 mmol) slowly at ꢀ20 ꢁC and stirred for
30 min at 0 ꢁC. After that, aldehyde (1.0 mmol) in solvent (0.25 mL)
was added at ꢀ40 ꢁC and stirred for 48 h at ꢀ20 ꢁC. The reaction
was quenched by addition of 1 N HCl aq and extracted with diethyl
ether. The combined organic layers were dried over Na2SO4, and
evaporated. The residue was purified by silica gel column chro-
matography (eluent: hexane/ethyl acetate¼3/1).
d
J¼9.2, 3.2 Hz, 1H, H2), 3.4e3.6 (m, 8H, OMe ꢂ2; H3; H4), 3.6e3.7 (m,
4H, OMe; H5), 3.81 (dd, J¼11.6, 4.0 Hz, 1H, H6), 3.87 (dd, J¼11.6, 4.0 Hz,
1H, H60), 4.86 (d, J¼3.2 Hz, 1H, H1), 13C NMR (100.6 MHz, CDCl3):
d
55.3, 55.5, 61.3, 62.4, 76.7, 81.9, 82.7, 97.5, HRMS [ESI]. m/z calcd for
C9H17O6: 221.1025 [MꢀH]ꢀ, found: 221.1025 [MꢀH]ꢀ.
3.2.4. Methyl 2,3-di-O-methyl-b-D-glucopyranoside (4). White solids;
mp 42 ꢁC (lit.12 mp 62e64 ꢁC); ½a 3D2
ꢃ
ꢀ41.3 (c 1.0, CHCl3) (lit.12
3.3.1. (S)-1-Phenylpropanol. ½a D27
ꢃ
ꢀ34.3 (c 1.00, CHCl3) (lit.16
½ ꢃ
a 2D9
[a
]Dꢀ47.8 (c 1.0, CHCl3)); IR (KBr) 614, 890, 955, 996, 1025, 1061,
þ41.9 (c 1.00, CHCl3, 96% ee (R))). The ee of the product was de-
termined as 84% ee (S) by HPLC analysis. tR of R-isomer, 15.1 min; tR of
S-isomer, 17.6 min [column, CHIRALCEL OD-H (DAICEL): eluent,
hexanee2-propanol (99:1), 1.0 mL/min]; 1H NMR (400 MHz, CDCl3):
1085, 1103, 3000e3700 (br) cmꢀ1; 1H NMR (400 MHz, CDCl3)
d 2.28
(br s, 1H, OH), 2.89 (br s, 1H, OH), 3.00 (dd, J¼9.2, 7.8 Hz, 1H, H2), 3.14
(dd, J¼9.1, 9.0 Hz, 1H, H4), 3.3e3.4 (m, 1H, H5), 3.51 (dd, J¼9.2, 9.1 Hz,
1H, H3), 3.56 (s, 3H, OMe), 3.58 (s, 3H, OMe), 3.64 (s, 3H, OMe), 3.7e4.0
(m, 2H, H6; H60), 4.25 (d, J¼7.8 Hz, 1H, H1), 13C NMR (100.6 MHz,
d
0.92 (t, J¼7.2 Hz, 3H, CH2CH3), 1.7e1.8 (m, 2H, CH2CH3), 4.61 (t,
J¼7.2 Hz, 1H, PhCH), 7.3e7.4 (m, 5H, PhH).
CDCl3): d 57.2, 60.2, 60.9, 62.5, 70.1, 74.7, 83.6, 95.6, 104.6, HRMS [ESI].
m/z calcd for C9H17O6: 221.1025 [MꢀH]ꢀ, found: 221.1025 [MꢀH]ꢀ.
3.3.2. (S)-1-(4-Chlorophenyl)-1-propanol. ½a D31
ꢀ15.1 (c 1.00, benzene)
ꢃ
(lit.16
½
a 2D9
ꢃ
þ24.1 (c 1.00, benzene, 90% ee (R))). The ee of the product
3.2.5. Methyl 2,3-di-O-methyl-
a
-
D
-mannopyranoside (5). White solids;
þ40.7 (c 1.0, CHCl3); IR (KBr) 614, 890, 955, 996, 1025,
2.13 (br s, 1H,
was determined as 67% ee (S) by HPLC analysis. tR of S-isomer,
12.2 min; tR of R-isomer, 13.0 min [column, CHIRALCEL OD-H (DAI-
CEL): eluent, hexanee2-propanol (95:5), 0.5 mL/min]; 1H NMR
mp 49 ꢁC; ½a 2D6
ꢃ
1061, 3000e3700 br cmꢀ1; 1H NMR (400 MHz, CDCl3)
d
OH), 2.50 (br s, 1H, OH), 3.3e3.7 (m, 12H, OMe ꢂ3; H2; H4; H5),
(400 MHz, CDCl3):
CH2CH3), 3.75 (s, 1H, OH), 4.61 (t, J¼6.4 Hz, 1H, ArCH), 7.2e7.4 (m, 4H,
ArH).
d
0.91 (t, J¼7.2 Hz, 3H, CH2CH3), 1.6e1.9 (m, 2H,
3.8e3.9 (m, 3H, H3; H6; H60), 4.82 (s, 1H, H1), 13C NMR (100.6 MHz,
CDCl3): d 54.9, 57.1, 59.1, 62.7, 67.1, 72.0, 75.8, 81.0, 98.5; HRMS [ESI]. m/
z calcd for C9H17O6: 221.1025 [MꢀH]ꢀ, found: 221.1025 [MꢀH]ꢀ.
3.3.3. (S)-1-(4-Methylphenyl)-1-propanol. ½a D31
ꢀ20.2 (c 0.77, ben-
ꢃ
3.2.6. Methyl 2,3-di-O-acetyl-
a
-
D
-glucopyranoside (6). Colorless oil;
zene) (lit.17
½
a 2D0
ꢃ
ꢀ38.5 (c 1.10, benzene, 90% ee (S))). The ee of the
½
a 2D9
ꢃ
þ149.2 (c 0.46, CHCl3) (lit.13
½
a 1D9
ꢃ
þ127 (c 0.46, CHCl3)); IR (KBr)
product was determined as 60% ee (S) by HPLC analysis. tR of R-isomer,